Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tobira Therapeutics
Biotech
Frazier hits $419M for early-stage biotech investments
California investment firm Frazier Healthcare Partners has gone over its hard cap target of $400 million as it looks to inject cash into early life science work.
Ben Adams
Nov 1, 2017 5:00am
Allergan buys another NASH biotech in M&A spree
Sep 21, 2016 6:22am
Reverse mergers take on 2016, as IPOs ready for 2017 comeback
Sep 20, 2016 12:22pm
Acquisitive Allergan buys micro-cap NASH biotech Tobira months after trial miss
Sep 20, 2016 8:36am
Small cap Tobira tanks on NASH trial miss
Jul 25, 2016 9:37am
Tobira and Korea's Dong-A ST sign $80M diabetes/NASH deal
Apr 11, 2016 10:47am